期刊文献+

从蛋白质组学探讨壮骨止痛方治疗骨质疏松症的作用机理 被引量:5

Analysis on Mechanism of Zhuanggu Zhitong Formula Treating Osteoporosis based on Proteomics
下载PDF
导出
摘要 目的:用蛋白质组学的方法研究壮骨止痛方治疗骨质疏松的作用机理。方法:建立去卵巢大鼠骨质疏松症模型,分为壮骨止痛方组、模型组、假手术组,13周后骨质疏松症模型成功,提取股骨组织蛋白质样品,双向电泳分离,得到各组股骨组织总蛋白质分子解剖图谱,用图像分析软件,分析各组间差异蛋白质点,MAlDI-TOF-MS质谱分析,结合蛋白质生物信息库(Marx science Ltd database),对各蛋白质初步鉴定。结论:鉴定了2个差异蛋白,分别P1为膜联蛋白A1,P2为蛋白质二硫键异构酶A3,初步认为这两种蛋白质在壮骨止痛方治疗该病过程中发挥着重要调控作用。 Objective:To study the mechanism about Zhuanggu Zhitong Formula treating OP based on proteomics. Methods : Bilateal OVX in rats was performed as osteoporosis model. Rats were randomly divided into three groups : control group, OP model group and Zhuanggu Zhitong Formula group. The pathology of bone was examined after 13 weeks. In the present proteomie study, we characterized the protential effects of OVX and Chinese medicine on protein expression in ratbones. Using two dimensional electrophoresis,mass spectrometry and Marx science Ltd database, we elementarily identi- fied three variational proteins. Conclusions:Two proteins were identified as proteins similar to Annexins A1, Protein disul- fide- isomerase A3. These proteins have been demonstrated to be postmenopausal proteins. These results can provide valuable experimental evidences for the research of the molecular mechanism of Zhuanggu Zhitong Formula treating OP.
出处 《中华中医药学刊》 CAS 2012年第11期2391-2393,I0001,共4页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(30873291) 湖南省中医药科技计划资助项目(2008032)
关键词 壮骨止痛方 蛋白质组学 骨质疏松症 双向电泳 Zhuanggu Zhitong Formula proteomics OP two - dimensional electrophoresis
  • 相关文献

参考文献6

二级参考文献26

  • 1Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation [ J ]. Nat Rev Immunol, 2009, 9 ( 1 ) : 62.
  • 2Lim LH, Pervaiz S. Annexin 1 : The new face of an old molecule [J]. FASEB J, 2007, 21 (4): 968.
  • 3Rosengarth A, Gerke V, Luecke H. X - ray structure of full - length annexin 1 and implications for membrane aggregation [J]. J Mol Biol, 2001, 306 (3): 489.
  • 4Hayhoe RP, Kamal AM, Solito E, et al. Annexin 1 and its bioactive peptide inhibit neutrophil - endothelium interactions under flow: Indication of distinct receptor involvement [ J ]. Blood, 2006, 107 (5): 2123.
  • 5Skouteris GG, Schroder CH. The hepatocyte growth factor receptor kinase - mediated phosphorylation of lipocortin - 1 transduces the proliferating signal of the hepatocyte growth factor [J]. J Biol Chem, 1996, 271 (44): 27266.
  • 6Perretti M, Solito E. Annexin 1 and neutrophil apoptosis [ J]. Biochem Soc Trans, 2004, 32 (Pt3) : 507.
  • 7Mussunoor S, Murray GI. The role of annexins in tumour development and progression [J]. J Pathol, 2008, 216 (2): 131.
  • 8Hu N, Flaig MJ, Su H, et al. Comprehensive characterization of armexin I alterations in esophageal squamous cell carcinoma [J]. Clin Cancer Res, 2004, 10 (18 Pt 1): 6013.
  • 9de Coupade C, Gillet R, Bennoun M, et al. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice [ J ]. Hepatology, 2000, 31 (2):371.
  • 10Hsiang CH, Tunoda T, Whang YE, et al. The impact of altered annexin I protein levels on apoptosis and signal transduetion pathways in prostate cancer cells [ J ]. Prostate, 2006, 66 (13): 1413.

共引文献15

同被引文献71

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部